Evidence map›Paper›PMID 39272010›Full record

ArticleBMC public health2024

The challenges and lessons from a formative process and value-based evaluation of the wave 1 roll-out of the all Wales Diabetes Prevention Programme.

Sharon N Parsons, Liv Kosnes, Pippa Anderson, Shaun Rs Harris, Rhys Thatcher, Barbara Harrington, Jan Davies, Deborah Fitzsimmons, Stephen D Luzio

Abstract read
In one paragraph

Article in BMC public health, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Sharon N ParsonsDiabetes Research Group, Faculty of Medicine, Health and Life Science, Swansea University, Swansea, UK. S.N.Parsons@Swansea.ac.uk.
Liv KosnesSwansea Centre for Health Economics, Faculty of Medicine, Health and Life Science, Swansea University, Swansea, UK.
Pippa AndersonSwansea Centre for Health Economics, Faculty of Medicine, Health and Life Science, Swansea University, Swansea, UK.
Shaun Rs HarrisSwansea Centre for Health Economics, Faculty of Medicine, Health and Life Science, Swansea University, Swansea, UK.
Rhys ThatcherDept of Life Sciences, Aberystwyth University, Aberystwyth, UK.
Barbara HarringtonDiabetes Research Group Swansea Public Reference Panel, Faculty of Medicine, Health and Life Science, Swansea University, Swansea, UK.
Jan DaviesDiabetes Research Group Swansea Public Reference Panel, Faculty of Medicine, Health and Life Science, Swansea University, Swansea, UK.
Deborah FitzsimmonsSwansea Centre for Health Economics, Faculty of Medicine, Health and Life Science, Swansea University, Swansea, UK.
Stephen D LuzioDiabetes Research Group, Faculty of Medicine, Health and Life Science, Swansea University, Swansea, UK.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe All Wales Diabetes Prevention Programme (AWDPP) is a Wales wide, public health initiative designed to systematically identify adults at risk of developing type 2 diabetes and offer a 30-minute person-centred lifestyle conversation focused on diet and physical activity. An independent formative process and value-based evaluation was commissioned to examine the implementation of this programme in 14 primary care cluster areas across Wales during the initial roll-out.

methodsThis evaluation was undertaken to ascertain the views on early implementation of the programme from service users, health care professionals and key stakeholders. The evaluation was informed by the Medical Research Council Framework for Process Evaluation and Wales Prudent Healthcare principles. As part of the value-based assessment, a preliminary cost-consequence analysis was conducted to understand the short-term economic impact of the implementation of the programme.

resultsService users who took part in the evaluation highly valued the programme and nearly half had been previously unaware that they were at risk of developing type 2 diabetes. Delivering the programme presented challenges but there was significant enthusiasm and support from all stakeholders. Overall, the programme was being delivered as intended albeit with evidence of some variation in the application of the programme eligibility criteria.

conclusionsIn Wave 1 of the AWDPP roll-out, the intent to deliver the programme in line with Prudent Healthcare was successful and promising in terms of demonstrating value. Opinions expressed by service users suggest the AWDPP matters to them; raising awareness, promoting knowledge and capacity to change behaviours and motivate and raise confidence.

Indexed as

Diabetes Mellitus, Type 2Program EvaluationAdultCost-Benefit AnalysisFemaleHealth PromotionHumansMaleMiddle AgedPrimary Health CareWalesPrediabetesPrevention and controlProgramme evaluationType 2 diabetes prevention

Identifiers

PMID39272010
PMCPMC11401378

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.